Australia, Feb. 17 -- GlaxoSmithKline Biologicals S.A, owns the trademark (2569920) for 'INFLENVY' till May 12, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical and medicinal preparations and substances; vaccines.]
Type of Mark: Word
Date of Acceptance: Sept. 9, 2025
Registration Advertised: Feb. 16
For further details contact Legal Brand Protection.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2569920.
Disclaimer: Curated by HT Syndication.
